Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Circulatory Support for High-Risk Coronary Artery Bypass Grafting and Coronary Interventions: Where is the Evidence?
Andrew J Gorton1, Suresh Keshavamurthy1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky, Lexington, Kentucky.
Insights
Mechanical circulatory support (MCS) devices help reduce risks for high-risk patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). This review examines evidence, patient groups, and outcomes for temporary MCS use.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Devices
Background:
- Coronary artery disease is a leading global cause of death.
- High-risk patients undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) face significant perioperative challenges.
- Mechanical circulatory support (MCS) devices are increasingly used to manage these risks.
Purpose of the Study:
- To review the evidence for temporary MCS in high-risk CABG and PCI.
- To define high-risk patient populations for these procedures.
- To compare the benefits, risks, and outcomes of different temporary MCS devices.
Main Methods:
- Literature review of studies on temporary mechanical circulatory support.
- Analysis of patient data to define high-risk criteria.
- Comparative assessment of device-specific performance and outcomes.
Main Results:
- Evidence supports the use of temporary MCS in select high-risk patients undergoing CABG and PCI.
- Specific patient characteristics identify high-risk individuals.
- Different MCS devices offer varying benefits and risks, impacting clinical outcomes.
Conclusions:
- Temporary MCS can mitigate perioperative risks in high-risk cardiac interventions.
- Careful patient selection and device choice are crucial for optimal outcomes.
- Further research is needed to refine indications and compare long-term effectiveness.
Abstract:
Coronary artery disease remains the leading cause of morbidity and mortality worldwide. Patients with ischemic cardiomyopathy or other high-risk features undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) present significant perioperative challenges due to elevated procedural risks. Mechanical circulatory support (MCS) devices such as the intra-aortic balloon pump, Impella devices, and venoarterial extracorporeal membrane oxygenation have increasingly been used to mitigate these risks. This review aims to evaluate the evidence supporting the use of temporary MCS in high-risk CABG and PCI, define high-risk patient populations, and compare device-specific benefits, risks, and clinical outcomes.

